|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$902,101
|
$180,420
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
|
5K08CA133103-02
|
$140,940
|
$140,940
|
Gutierrez, Alejandro
|
DANA-FARBER CANCER INSTITUTE
|
|
WUMC Cancer and Leukemia Group B
|
2U10CA077440-12
|
$345,040
|
$20,702
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Validating Syk as a Target for AML Therapy
|
1R01CA140292-01
|
$357,937
|
$357,937
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INSTITUTE
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-05
|
$320,964
|
$109,128
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
3P50CA100632-07S1
|
$52,857
|
$3,700
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-07
|
$2,300,000
|
$161,000
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-05S2
|
$60,764
|
$7,899
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-05
|
$1,371,380
|
$178,279
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
Toward Defining the Functional Methylome in Acute Lymphoblastic Leukemia
|
1K99CA132784-01A1
|
$113,213
|
$113,213
|
TAYLOR, KRISTEN
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
|
The Role of Oncogenic Ras in Leukemogenesis and Response to Targeted Therapies
|
7K08CA134649-02
|
$127,170
|
$127,170
|
Li, Qing
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The role of AKT signaling in NOTCH1 induced leukemias
|
5R01CA129382-02
|
$341,043
|
$170,522
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-16S1
|
$73,969
|
$1,479
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-16S2
|
$99,471
|
$1,989
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-16S3
|
$83,979
|
$1,680
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-16
|
$5,084,061
|
$101,681
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY
|
|
The molecular role of lkaros in leukemogenesis
|
5R01CA104962-04
|
$204,847
|
$102,424
|
WINANDY, SUSAN
|
NORTHWESTERN UNIVERSITY
|
|
TEL-AML1 Transgenic Zebrafish Model of Human Leukemia
|
5K22CA120626-03
|
$162,960
|
$162,960
|
Sabaawy, Hatem
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Targeting MLL As Anticancer Therapy for Infant Acute Lymphoblastic Leukemia
|
1R43CA141903-01
|
$130,694
|
$130,694
|
Burkhart, Catherine
|
BUFFALO BIOLABS, LLC
|
|
Targeted therapy of ALL with gene-modified central memory T cells
|
1R01CA136551-01A1
|
$551,563
|
$275,782
|
Riddell, Stanley
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted therapy for 11q23 acute leukemias
|
2R01CA098459-04A2
|
$202,994
|
$101,497
|
HEMENWAY, CHARLES
|
LOYOLA UNIVERSITY CHICAGO
|
|
Symptom Cluster Subgroups in Adult Survivors of Childhood Cancers
|
1R01CA136912-01A2
|
$239,033
|
$23,903
|
Finnegan, Lorna
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Support for Human Specimen Banking in NCI-Supported Cancer Clinical Trials
|
5U24CA114766-05
|
$1,195,618
|
$239,124
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04020
|
$2,310
|
$577
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04033
|
$172,949
|
$172,949
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-04122
|
$194,069
|
$194,069
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
ZIA CP010131-10481
|
$32,787
|
$26,229
|
Berrington, Amy
|
DCEG (NCI)
|
|
Studies of Immune Functions in Patients with Fanconi Anemia
|
ZIA CP010144-10475
|
$48,647
|
$48,647
|
Giri
|
DCEG (NCI)
|
|
Studies of BCR/ABL Leukemogenesis in Mice
|
5R01CA090576-10
|
$286,110
|
$143,055
|
Van Etten, Richard
|
TUFTS MEDICAL CENTER
|
|
Stanford University Cancer Center
|
3P30CA124435-03S1
|
$126,467
|
$1,265
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
5P30CA124435-03
|
$1,611,344
|
$16,113
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes
|
ZIA BC 010692
|
$72,399
|
$14,480
|
Arthur, Diane
|
CCR (NCI)
|
|
Roles and Regulation of p53
|
5P01CA087497-09
|
$1,639,011
|
$81,951
|
Prives, Carol
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Role of PBX Proteins in Hematopoiesis and Growth Control
|
5R01CA090735-09
|
$300,009
|
$300,009
|
CLEARY, MICHAEL
|
STANFORD UNIVERSITY
|
|
Role of miR155 in Leukemogenesis
|
5R01CA124541-02
|
$330,797
|
$165,399
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
Role of 11q23 Chromosome Abnormalities in the Causation of Acute Leukemia
|
1P01CA129242-01A2
|
$1,011,385
|
$1,011,385
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
Risk Factors for TEL-AML Fusion Genes and Childhood Acute Lymphoblastic Leukemia
|
5R03CA133960-02
|
$54,000
|
$54,000
|
Ezzat, Sameera
|
NATL HEPATOLOGY/TROPICAL MED RES INST
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
5R01CA113969-05
|
$318,664
|
$79,666
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
|
Research Management and Support
|
RMS2009 [E]
|
$350,982,837
|
$35,000
|
N/A
|
National Cancer Institute
|
|
Relapse after Allogeneci Hematopoietic Stem Cell Transplantation
|
ZIA BC 011239
|
$167,837
|
$16,784
|
Bishop, Michael
|
CCR (NCI)
|
|
Radiologial Physics Center
|
5U10CA010953-41
|
$2,487,286
|
$323,347
|
IBBOTT, GEOFFREY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Quality Assurance Review Center
|
5U10CA029511-30
|
$1,737,151
|
$225,830
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Promoting Treatment Adherence in Adolescent Leukemia
|
5R01CA119162-03
|
$90,274
|
$90,274
|
Drotar, Dennis
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Prenatal adenovirus infection, inhibition of DNA repair, and childhood leukemia
|
1R01CA127621-01A2
|
$426,319
|
$426,319
|
Ornelles, David
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Postgraduate Training in Pediatric Oncology
|
5T32CA082086-10
|
$198,863
|
$49,716
|
HUNGER, STEPHEN
|
UNIVERSITY OF COLORADO DENVER
|
|
Physical Activity to Modify Sequelae and QOL in Childhood ALL: A Nursing Trial
|
1R01CA129384-01A2
|
$1,023,985
|
$1,023,985
|
COX, CHERYL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)
|
5R37CA036401-26
|
$590,109
|
$590,109
|
EVANS, WILLIAM
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Pharmacogenetics of Ara-C Metabolic Pathway
|
7R01CA132946-02
|
$299,001
|
$149,501
|
Lamba, Jatinder
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 010764
|
$2,324,038
|
$464,808
|
Wayne, Alan
|
CCR (NCI)
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-31
|
$223,195
|
$33,479
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Childhood Leukemia for this search: $47,255,992
|